Day, Michaela J.Spiteri, GianfrancoJacobsson, SusanneWoodford, NeilAmato-Gauci, Andrew J.Cole, Michelle J.Unemo, MagnusEuro-GASP network2020-09-172020-09-172018-12-03BMC Infect Dis. 2018 Dec 3;18(1):609. doi: 10.1186/s12879-018-3528-41471-2334http://hdl.handle.net/10400.18/7209Euro-GASP network Participants: Portugal (Jacinta Azevedo,Maria-José Borrego). Maria-José Borrego - Departamento de Doenças Infeciosas do INSA.The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the European Union/European Economic Area (EU/EEA). We present the Euro-GASP results from 2016 (25 countries), linked to patient epidemiological data, and compared with data from previous years.engAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxoneChildChild, PreschoolCiprofloxacinDiagnostic Tests, RoutineEuropeFemaleGentamicinsGonorrheaHumansInfantMaleMicrobial Sensitivity TestsMiddle AgedNeisseria gonorrhoeaeSentinel SurveillanceSpectinomycinYoung AdultDrug Resistance, BacterialInfecções Sexualmente Transmissíveisjournal article10.1186/s12879-018-3528-4